TY - JOUR AU - Alamanos, Y. AU - Drosos, A. A. PY - 2005 DA - 2005// TI - Epidemiology of adult rheumatoid arthritis JO - Autoimmun Rev VL - 4 UR - https://doi.org/10.1016/j.autrev.2004.09.002 DO - 10.1016/j.autrev.2004.09.002 ID - Alamanos2005 ER - TY - JOUR AU - Bykerk, V. P. AU - Keystone, E. C. AU - Kuriya, B. AU - Larche, M. AU - Thorne, J. C. AU - Haraoui, B. PY - 2013 DA - 2013// TI - Achieving remission in clinical practice: lessons from clinical trial data JO - Clin Exp Rheumatol VL - 31 ID - Bykerk2013 ER - TY - JOUR AU - Smolen, J. S. AU - Keystone, E. C. AU - Emery, P. AU - Breedveld, F. C. AU - Betteridge, N. AU - Burmester, G. R. PY - 2007 DA - 2007// TI - Consensus statement on the use of rituximab in patients with rheumatoid arthritis JO - Ann Rheum Dis VL - 66 UR - https://doi.org/10.1136/ard.2006.061002 DO - 10.1136/ard.2006.061002 ID - Smolen2007 ER - TY - JOUR AU - Smolen, J. S. AU - Landewe, R. AU - Breedveld, F. C. AU - Buch, M. AU - Burmester, G. AU - Dougados, M. PY - 2014 DA - 2014// TI - EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update JO - Ann Rheum Dis VL - 73 UR - https://doi.org/10.1136/annrheumdis-2013-204573 DO - 10.1136/annrheumdis-2013-204573 ID - Smolen2014 ER - TY - JOUR AU - Singh, J. A. AU - Cameron, D. R. PY - 2012 DA - 2012// TI - Summary of AHRQ’s comparative effectiveness review of drug therapy for rheumatoid arthritis (RA) in adults--an update JO - J Manag Care Pharm VL - 18 ID - Singh2012 ER - TY - JOUR AU - Ferraccioli, G. AU - Tolusso, B. AU - Bobbio-Pallavicini, F. AU - Gremese, E. AU - Ravagnani, V. AU - Benucci, M. PY - 2012 DA - 2012// TI - Biomarkers of good EULAR response to the B cell depletion therapy in all seropositive rheumatoid arthritis patients: clues for the pathogenesis JO - PLoS One VL - 7 UR - https://doi.org/10.1371/journal.pone.0040362 DO - 10.1371/journal.pone.0040362 ID - Ferraccioli2012 ER - TY - JOUR AU - Soliman, M. M. AU - Hyrich, K. L. AU - Lunt, M. AU - Watson, K. D. AU - Symmons, D. P. AU - Ashcroft, D. M. PY - 2012 DA - 2012// TI - Effectiveness of rituximab in patients with rheumatoid arthritis: observational study from the British Society for Rheumatology Biologics Register JO - J Rheumatol VL - 39 UR - https://doi.org/10.3899/jrheum.110610 DO - 10.3899/jrheum.110610 ID - Soliman2012 ER - TY - JOUR AU - Daien, C. I. AU - Morel, J. PY - 2014 DA - 2014// TI - Predictive factors of response to biological disease modifying antirheumatic drugs: towards personalized medicine JO - Mediators Inflamm VL - 2014 UR - https://doi.org/10.1155/2014/386148 DO - 10.1155/2014/386148 ID - Daien2014 ER - TY - JOUR AU - Buch, M. H. AU - Smolen, J. S. AU - Betteridge, N. AU - Breedveld, F. C. AU - Burmester, G. AU - Dorner, T. PY - 2011 DA - 2011// TI - Updated consensus statement on the use of rituximab in patients with rheumatoid arthritis JO - Ann Rheum Dis VL - 70 UR - https://doi.org/10.1136/ard.2010.144998 DO - 10.1136/ard.2010.144998 ID - Buch2011 ER - TY - JOUR AU - Quartuccio, L. AU - Fabris, M. AU - Salvin, S. AU - Atzeni, F. AU - Saracco, M. AU - Benucci, M. PY - 2009 DA - 2009// TI - Rheumatoid factor positivity rather than anti-CCP positivity, a lower disability and a lower number of anti-TNF agents failed are associated with response to rituximab in rheumatoid arthritis JO - Rheumatology VL - 48 UR - https://doi.org/10.1093/rheumatology/kep314 DO - 10.1093/rheumatology/kep314 ID - Quartuccio2009 ER - TY - JOUR AU - Benucci, M. AU - Manfredi, M. AU - Puttini, P. S. AU - Atzeni, F. PY - 2010 DA - 2010// TI - Predictive factors of response to rituximab therapy in rheumatoid arthritis: What do we know today? JO - Autoimmun Rev VL - 9 UR - https://doi.org/10.1016/j.autrev.2010.07.006 DO - 10.1016/j.autrev.2010.07.006 ID - Benucci2010 ER - TY - JOUR AU - Toubi, E. AU - Kessel, A. AU - Slobodin, G. AU - Boulman, N. AU - Pavlotzky, E. AU - Zisman, D. PY - 2007 DA - 2007// TI - Changes in macrophage function after rituximab treatment in patients with rheumatoid arthritis JO - Ann Rheum Dis VL - 66 UR - https://doi.org/10.1136/ard.2006.062505 DO - 10.1136/ard.2006.062505 ID - Toubi2007 ER - TY - JOUR AU - Vancsa, A. AU - Szabo, Z. AU - Szamosi, S. AU - Bodnar, N. AU - Vegh, E. AU - Gergely, L. PY - 2013 DA - 2013// TI - Longterm effects of rituximab on B cell counts and autoantibody production in rheumatoid arthritis: use of high-sensitivity flow cytometry for more sensitive assessment of B cell depletion JO - J Rheumatol VL - 40 UR - https://doi.org/10.3899/jrheum.111488 DO - 10.3899/jrheum.111488 ID - Vancsa2013 ER - TY - JOUR AU - Willemze, A. AU - Bohringer, S. AU - Knevel, R. AU - Levarht, E. W. AU - Stoeken-Rijsbergen, G. AU - Houwing-Duistermaat, J. J. PY - 2012 DA - 2012// TI - The ACPA recognition profile and subgrouping of ACPA-positive RA patients JO - Ann Rheum Dis VL - 71 UR - https://doi.org/10.1136/annrheumdis-2011-200421 DO - 10.1136/annrheumdis-2011-200421 ID - Willemze2012 ER - TY - JOUR AU - Steendam, K. AU - Tilleman, K. AU - Ceuleneer, M. AU - Keyser, F. AU - Elewaut, D. AU - Deforce, D. PY - 2010 DA - 2010// TI - Citrullinated vimentin as an important antigen in immune complexes from synovial fluid of rheumatoid arthritis patients with antibodies against citrullinated proteins JO - Arthritis Res Ther VL - 12 UR - https://doi.org/10.1186/ar3070 DO - 10.1186/ar3070 ID - Steendam2010 ER - TY - JOUR AU - Qin, X. AU - Deng, Y. AU - Xu, J. AU - Li, T. J. AU - Li, S. AU - Zhao, J. M. PY - 2011 DA - 2011// TI - Meta-analysis: diagnostic value of serum anti-mutated citrullinated vimentin antibodies in patients with rheumatoid arthritis JO - Rheumatol Int VL - 31 UR - https://doi.org/10.1007/s00296-009-1343-3 DO - 10.1007/s00296-009-1343-3 ID - Qin2011 ER - TY - JOUR AU - Ioan-Facsinay, A. AU - Willemze, A. AU - Robinson, D. B. AU - Peschken, C. A. AU - Markland, J. AU - Woude, D. PY - 2008 DA - 2008// TI - Marked differences in fine specificity and isotype usage of the anti-citrullinated protein antibody in health and disease JO - Arthritis Rheum VL - 58 UR - https://doi.org/10.1002/art.23763 DO - 10.1002/art.23763 ID - Ioan-Facsinay2008 ER - TY - JOUR AU - Zahran, W. E. AU - Mahmoud, M. I. AU - Shalaby, K. A. AU - Abbas, M. H. PY - 2013 DA - 2013// TI - Unique correlation between mutated citrullinated vimentine IgG autoantibodies and markers of systemic inflammation in rheumatoid arthritis patients JO - Indian J Clin Biochem VL - 28 UR - https://doi.org/10.1007/s12291-012-0272-1 DO - 10.1007/s12291-012-0272-1 ID - Zahran2013 ER - TY - JOUR AU - Svard, A. AU - Kastbom, A. AU - Soderlin, M. K. AU - Reckner-Olsson, A. AU - Skogh, T. PY - 2011 DA - 2011// TI - A comparison between IgG- and IgA-class antibodies to cyclic citrullinated peptides and to modified citrullinated vimentin in early rheumatoid arthritis and very early arthritis JO - J Rheumatol VL - 38 UR - https://doi.org/10.3899/jrheum.101086 DO - 10.3899/jrheum.101086 ID - Svard2011 ER - TY - JOUR AU - Aletaha, D. AU - Neogi, T. AU - Silman, A. J. AU - Funovits, J. AU - Felson, D. T. AU - Bingham, C. O. PY - 2010 DA - 2010// TI - 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative JO - Arthritis Rheum VL - 62 UR - https://doi.org/10.1002/art.27584 DO - 10.1002/art.27584 ID - Aletaha2010 ER - TY - JOUR AU - Fransen, J. AU - Riel, P. L. PY - 2009 DA - 2009// TI - The Disease Activity Score and the EULAR response criteria JO - Rheum Dis Clin North Am VL - 35 UR - https://doi.org/10.1016/j.rdc.2009.10.001 DO - 10.1016/j.rdc.2009.10.001 ID - Fransen2009 ER - TY - STD TI - van Riel PL. The development of the disease activity score (DAS) and the disease activity score using 28 joint counts (DAS28). Clin Exp Rheumatol. 2014;32 5 Suppl 85:S-65–74. ID - ref22 ER - TY - JOUR AU - Leandro, M. J. PY - 2013 DA - 2013// TI - B-cell subpopulations in humans and their differential susceptibility to depletion with anti-CD20 monoclonal antibodies JO - Arthritis Res Ther VL - 15 UR - https://doi.org/10.1186/ar3908 DO - 10.1186/ar3908 ID - Leandro2013 ER - TY - JOUR AU - Nakou, M. AU - Katsikas, G. AU - Sidiropoulos, P. AU - Bertsias, G. AU - Papadimitraki, E. AU - Raptopoulou, A. PY - 2009 DA - 2009// TI - Rituximab therapy reduces activated B cells in both the peripheral blood and bone marrow of patients with rheumatoid arthritis: depletion of memory B cells correlates with clinical response JO - Arthritis Res Ther VL - 11 UR - https://doi.org/10.1186/ar2798 DO - 10.1186/ar2798 ID - Nakou2009 ER - TY - JOUR AU - Sellam, J. AU - Rouanet, S. AU - Hendel-Chavez, H. AU - Abbed, K. AU - Sibilia, J. AU - Tebib, J. PY - 2011 DA - 2011// TI - Blood memory B cells are disturbed and predict the response to rituximab in patients with rheumatoid arthritis JO - Arthritis Rheum VL - 63 UR - https://doi.org/10.1002/art.30599 DO - 10.1002/art.30599 ID - Sellam2011 ER - TY - JOUR AU - Trouvin, A. P. AU - Jacquot, S. AU - Grigioni, S. AU - Curis, E. AU - Dedreux, I. AU - Roucheux, A. PY - 2015 DA - 2015// TI - Usefulness of monitoring of B cell depletion in rituximab-treated rheumatoid arthritis patients in order to predict clinical relapse: a prospective observational study JO - Clin Exp Immunol VL - 180 UR - https://doi.org/10.1111/cei.12481 DO - 10.1111/cei.12481 ID - Trouvin2015 ER - TY - JOUR AU - McHeyzer-Williams, M. AU - Okitsu, S. AU - Wang, N. AU - McHeyzer-Williams, L. PY - 2012 DA - 2012// TI - Molecular programming of B cell memory JO - Nat Rev Immunol VL - 12 ID - McHeyzer-Williams2012 ER - TY - JOUR AU - Yoshida, T. AU - Mei, H. AU - Dorner, T. AU - Hiepe, F. AU - Radbruch, A. AU - Fillatreau, S. PY - 2010 DA - 2010// TI - Memory B and memory plasma cells JO - Immunol Rev VL - 237 UR - https://doi.org/10.1111/j.1600-065X.2010.00938.x DO - 10.1111/j.1600-065X.2010.00938.x ID - Yoshida2010 ER - TY - JOUR AU - Kurosaki, T. AU - Kometani, K. AU - Ise, W. PY - 2015 DA - 2015// TI - Memory B cells JO - Nat Rev Immunol VL - 15 UR - https://doi.org/10.1038/nri3802 DO - 10.1038/nri3802 ID - Kurosaki2015 ER - TY - JOUR AU - DiLillo, D. J. AU - Hamaguchi, Y. AU - Ueda, Y. AU - Yang, K. AU - Uchida, J. AU - Haas, K. M. PY - 2008 DA - 2008// TI - Maintenance of long-lived plasma cells and serological memory despite mature and memory B cell depletion during CD20 immunotherapy in mice JO - J Immunol VL - 180 UR - https://doi.org/10.4049/jimmunol.180.1.361 DO - 10.4049/jimmunol.180.1.361 ID - DiLillo2008 ER - TY - JOUR AU - Westra, J. AU - Assen, S. AU - Wilting, K. R. AU - Land, J. AU - Horst, G. AU - Haan, A. PY - 2014 DA - 2014// TI - Rituximab impairs immunoglobulin (Ig)M and IgG (subclass) responses after influenza vaccination in rheumatoid arthritis patients JO - Clin Exp Immunol VL - 178 UR - https://doi.org/10.1111/cei.12390 DO - 10.1111/cei.12390 ID - Westra2014 ER - TY - JOUR AU - Teitsson, I. PY - 1988 DA - 1988// TI - IgA rheumatoid factor as predictor of disease activity JO - Scand J Rheumatol Suppl VL - 75 UR - https://doi.org/10.3109/03009748809096769 DO - 10.3109/03009748809096769 ID - Teitsson1988 ER - TY - JOUR AU - Rantapaa-Dahlqvist, S. AU - Jong, B. A. AU - Berglin, E. AU - Hallmans, G. AU - Wadell, G. AU - Stenlund, H. PY - 2003 DA - 2003// TI - Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis JO - Arthritis Rheum VL - 48 UR - https://doi.org/10.1002/art.11223 DO - 10.1002/art.11223 ID - Rantapaa-Dahlqvist2003 ER - TY - JOUR AU - Bobbio-Pallavicini, F. AU - Caporali, R. AU - Alpini, C. AU - Avalle, S. AU - Epis, O. M. AU - Klersy, C. PY - 2007 DA - 2007// TI - High IgA rheumatoid factor levels are associated with poor clinical response to tumour necrosis factor alpha inhibitors in rheumatoid arthritis JO - Ann Rheum Dis VL - 66 UR - https://doi.org/10.1136/ard.2006.060608 DO - 10.1136/ard.2006.060608 ID - Bobbio-Pallavicini2007 ER - TY - JOUR AU - Torre, I. AU - Leandro, M. J. AU - Valor, L. AU - Becerra, E. AU - Edwards, J. C. AU - Cambridge, G. PY - 2012 DA - 2012// TI - Total serum immunoglobulin levels in patients with RA after multiple B-cell depletion cycles based on rituximab: relationship with B-cell kinetics JO - Rheumatology VL - 51 UR - https://doi.org/10.1093/rheumatology/ker417 DO - 10.1093/rheumatology/ker417 ID - Torre2012 ER - TY - JOUR AU - Mei, H. E. AU - Yoshida, T. AU - Sime, W. AU - Hiepe, F. AU - Thiele, K. AU - Manz, R. A. PY - 2009 DA - 2009// TI - Blood-borne human plasma cells in steady state are derived from mucosal immune responses JO - Blood VL - 113 UR - https://doi.org/10.1182/blood-2008-04-153544 DO - 10.1182/blood-2008-04-153544 ID - Mei2009 ER - TY - JOUR AU - Mei, H. E. AU - Frolich, D. AU - Giesecke, C. AU - Loddenkemper, C. AU - Reiter, K. AU - Schmidt, S. PY - 2010 DA - 2010// TI - Steady-state generation of mucosal IgA+ plasmablasts is not abrogated by B-cell depletion therapy with rituximab JO - Blood VL - 116 UR - https://doi.org/10.1182/blood-2010-01-266536 DO - 10.1182/blood-2010-01-266536 ID - Mei2010 ER - TY - JOUR AU - Hasegawa, H. AU - Reit, E. AU - Kida, H. PY - 2015 DA - 2015// TI - Mucosal immunization and adjuvants JO - Curr Top Microbiol Immunol VL - 386 ID - Hasegawa2015 ER - TY - JOUR AU - Koziel, J. AU - Mydel, P. AU - Potempa, J. PY - 2014 DA - 2014// TI - The link between periodontal disease and rheumatoid arthritis: an updated review JO - Curr Rheumatol Rep VL - 16 UR - https://doi.org/10.1007/s11926-014-0408-9 DO - 10.1007/s11926-014-0408-9 ID - Koziel2014 ER - TY - JOUR AU - Taneja, V. PY - 2014 DA - 2014// TI - Arthritis susceptibility and the gut microbiome JO - FEBS Lett VL - 588 UR - https://doi.org/10.1016/j.febslet.2014.05.034 DO - 10.1016/j.febslet.2014.05.034 ID - Taneja2014 ER - TY - JOUR AU - Hvatum, M. AU - Kanerud, L. AU - Hallgren, R. AU - Brandtzaeg, P. PY - 2006 DA - 2006// TI - The gut-joint axis: cross reactive food antibodies in rheumatoid arthritis JO - Gut VL - 55 UR - https://doi.org/10.1136/gut.2005.076901 DO - 10.1136/gut.2005.076901 ID - Hvatum2006 ER -